UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in IDYA — IDEAYA Biosciences, Inc.
CIK 861177
NEW YORK, NY
Position in IDYA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,836,028
-$183,433 QoQ
Shares Held
175,151
+0.6% QoQ
Ownership
0.199%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
16 quarters on record
Voting authority
Sole 48.77505695085954.ToString("F0")%
Shared 0.ToString("F0")%
None 51.22494304914046.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. IDYA ranks #60 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in IDYA
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,836,028 | 175,151 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $6,019,461 | 174,124 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,481,259 | 201,443 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,731,310 | 272,660 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,965,512 | 303,145 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $8,308,446 | 323,286 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,089,950 | 318,496 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $10,964,041 | 312,277 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $10,159,006 | 231,518 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,752,510 | 274,101 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $7,295,145 | 270,391 | Shares | Defined | 2023-11-13 | |
| 2022-12-31 | $582,748 | 32,072 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $224,889 | 15,073 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $139,380 | 10,100 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $113,019 | 10,100 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $238,764 | 10,100 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||